Cargando…
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
BACKGROUND: Pharmaceuticals with targets in the cholinergic transmission have been used for decades and are still fundamental treatments in many diseases and conditions today. Both the transmission and the effects of the somatomotoric and the parasympathetic nervous systems may be targeted by such t...
Autores principales: | Soukup, Ondrej, Winder, Michael, Killi, Uday Kumar, Wsol, Vladimir, Jun, Daniel, Kuca, Kamil, Tobin, Gunnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543679/ https://www.ncbi.nlm.nih.gov/pubmed/27281175 http://dx.doi.org/10.2174/1570159X14666160607212615 |
Ejemplares similares
-
Inhibition of Nitric Oxide Synthase Prevents Muscarinic and Purinergic Functional Changes and Development of Cyclophosphamide-Induced Cystitis in the Rat
por: Aronsson, Patrik, et al.
Publicado: (2014) -
Characterization of Prejunctional Muscarinic Receptors: Effects on the Release of VIP and Functional Responses and Receptor Expression in the Ovine Submandibular Gland
por: Ryberg, Anders T., et al.
Publicado: (2009) -
7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment
por: Korabecny, Jan, et al.
Publicado: (2015) -
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
por: Čolović, Mirjana B, et al.
Publicado: (2013) -
Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive Targets
por: Alves-Lopes, Rhéure, et al.
Publicado: (2019)